Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
The Opportunity:
This is an exciting opportunity to advance first-in-Class RAS(ON) Inhibitors through clinical development. The ideal candidate is an experienced program manager with a thorough understanding of the stages of clinical drug development. This position works across teams to create cross-functional project plans and ensures their timely execution. The successful candidate will draw on their experience to:
Create project management solutions for functional leaders to improve decision-making and provide a portfolio view of accountabilities and milestones.
Creates dashboards that integrate activities across projects to inform prioritization and resource allocation decisions.
Proactively identifies project risks and engages functional leaders to design and implement solutions.
Leads cross-molecule meetings with function leads to ensure the timely delivery of program goals and cross-functional objectives.
Provides direction to functional teams on near-term milestones, priorities and potential risks to project execution.
Evaluates and recommends process improvements to further advance RevMed’s program management methodology.
Enthusiastically supports new corporate development activities or other initiatives supporting department, portfolio, or corporate needs.
Support cross-functional sub-teams across clinical assets per evolving business needs including preparing agendas, minutes, and follow-up on action items.
Required Skills, Experience and Education:
B.A. or BSc. In Life Sciences with 8 years’ experience in the biotech/pharmaceutical industry or MSc./MBA and 6 years of relevant experience; a minimum of 2 years of project management experience in drug development.
Outstanding verbal and written communication skills including the ability to summarize complex information into simple concepts for broad communication to project teams as well as for management status reports.
Broad knowledge of the clinical drug development process and regulations, coupled with strong proficiency in project management practices, tools, and methodology.
Highly organized, detail-oriented, diplomatic and calm under pressure.
Experience using Project Management software to manage project timelines and resources (e.g. MS Project, Smartsheet, Office Timeline Pro, and OnePager Pro etc.) and proficient with MS Office suite, video conferencing tools, and other internal document archiving systems (e.g., Egnyte, SharePoint).
Preferred Skills:
PMP (Project Management Professional) or other PM certification or equivalent preferred.
Experience in Oncology therapeutic area and clinical stages of drug development is strongly preferrable.
#LI-Hybrid #LI-EM1
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicines Redwood, California, USA Office
700 Saginaw Dr.,, , Redwood, California , United States, 94063
Similar Jobs
What you need to know about the San Francisco Tech Scene
Key Facts About San Francisco Tech
- Number of Tech Workers: 365,500; 13.9% of overall workforce (2024 CompTIA survey)
- Major Tech Employers: Google, Apple, Salesforce, Meta
- Key Industries: Artificial intelligence, cloud computing, fintech, consumer technology, software
- Funding Landscape: $50.5 billion in venture capital funding in 2024 (Pitchbook)
- Notable Investors: Sequoia Capital, Andreessen Horowitz, Bessemer Venture Partners, Greylock Partners, Khosla Ventures, Kleiner Perkins
- Research Centers and Universities: Stanford University; University of California, Berkeley; University of San Francisco; Santa Clara University; Ames Research Center; Center for AI Safety; California Institute for Regenerative Medicine
